abrdn Life Sciences Investors - Common (HQL)

CUSIP: 87911K100

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class
Equity / Common
Shares outstanding
29,948,325
Total 13F shares
2,302,053
Share change
+189,681
Total reported value
$64,980,792
Price per share
$28.21
Number of holders
41
Value change
+$5,330,725
Number of buys
20
Number of sells
17

Quarterly Holders Quick Answers

What is CUSIP 87911K100?
CUSIP 87911K100 identifies HQL - abrdn Life Sciences Investors - Common in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of abrdn Life Sciences Investors - Common (HQL) as of Q2 2015

As of 30 Jun 2015, abrdn Life Sciences Investors - Common (HQL) was held by 41 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,302,053 shares. The largest 10 holders included MORGAN STANLEY, NEEDHAM INVESTMENT MANAGEMENT LLC, WELLS FARGO & COMPANY/MN, Advisors Asset Management, Inc., UBS Group AG, LPL Financial LLC, FIRST TRUST ADVISORS LP, CREDIT SUISSE AG/, OPPENHEIMER & CO INC, and AMERICAN INTERNATIONAL GROUP INC. This page lists 41 institutional shareholders reporting positions in this security for the Q2 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.